ScripIndia could step up to the plate with a vaccine to prevent mpox, classified as a public health emergency of international concern (PHEIC) once again post 2022 by the World Health Organization (WHO) af
In VivoIndustry heads at a recent conclave discussed some of the key issues weighing on India’s ascent up the innovation value chain including the criticality of a robust domestic market for novel products,
ScripIndustry heads at a recent conclave discussed some of the key issues weighing on India’s ascent up the innovation value chain including the criticality of a robust domestic market for novel products,
ScripGlaxoSmithKline Pharmaceuticals Ltd. has eased out its bivalent human papillomavirus (HPV) vaccine, Cervarix, from the Indian market amid signs of low demand and the imminent debut of Serum Institut